Patents by Inventor Cedric-Olivier Turrin

Cedric-Olivier Turrin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DENDRIMERS HAVING THIOPHOSPHORAMIDATE PATTERNS AND DERIVATIVES
    Publication number: 20240116963
    Abstract: The present invention relates to new dendrimers with thiophosphoramidate units and derivatives, their preparation method and their use.
    Type: Application
    Filed: December 22, 2020
    Publication date: April 11, 2024
    Inventors: Abdelouahd OUKHRIB, Julien AUJARD-CATOT, Rèmy POUPOT, Cèdric-Olivier TURRIN
  • ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF PSORIASIS
    Publication number: 20230085651
    Abstract: The present invention relates to sugar-derived catanionic surfactant vesicles comprising anti-inflammatory dendrimers and to their use as a medicament, more particularly in the treatment of psoriasis.
    Type: Application
    Filed: December 22, 2020
    Publication date: March 23, 2023
    Inventors: Muriel BLANZAT, Ranime JEBBAWI, Rémy POUPOT, Cédric-Olivier TURRIN, Michel SIMON, Emily CLEMENT, Hélène LABIE, Abdelouahd OUKHRIB
  • Phosphorylated dendrimers as antiinflammatory drugs
    Patent number: 10106565
    Abstract: Dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: October 23, 2018
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PAUL SABATIER (TOULOUSE III)
    Inventors: Mary Poupot, Remy Poupot, Jean-Jacques Fournie, Damien Portevin, Severine Fruchon, Jean-Luc Davignon, Cedric-Olivier Turrin, Anne-Marie Caminade, Jean-Pierre Majoral, Olivier Rolland
  • Use of dendrimers to stimulate cell growth
    Patent number: 8815834
    Abstract: The present invention relates to the use of dendrimers with monophosphonic or bisphosphonic terminations in order to stimulate the growth of cell cultures or to activate cells in culture.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: August 26, 2014
    Assignees: Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Rhodia UK Limited
    Inventors: Jean-Pierre Majoral, Anne-Marie Jeannine Jacqueline Caminade, Jean-Jacques Fournie, Laurent Griffe, Mary Poupot-Marsan, Rémy Poupot, Cédric-Olivier Turrin
  • DENDRIMERS WITH A SACCHARIDE ENDING FOR ANTI-INFLAMMATORY PURPOSES
    Publication number: 20130274210
    Abstract: The present invention relates to dendrimers with a monosaccharide, oligosaccharide or polysaccharide terminal group, to their preparation method and their therapeutic uses, notably anti-inflammatory uses.
    Type: Application
    Filed: August 31, 2011
    Publication date: October 17, 2013
    Applicant: UNIVERSITE PAUL SABATIER TOULOUSE III
    Inventors: Jacques Prandi, Germain Puzo, Cédric-Olivier Turrin, Emilyne Blattes, Alain Vercellone, Jérôme Nigou, Jean-Pierre Majoral, Anne-Marie Caminade
  • Use of Dendrimers to Stimulate Cell Growth
    Publication number: 20090142316
    Abstract: The present invention relates to the use of dendrimers with monophosphonic or bisphosphonic terminations in order to stimulate the growth of cell cultures or to activate cells in culture.
    Type: Application
    Filed: July 29, 2005
    Publication date: June 4, 2009
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M, RHODIA UK LIMITED
    Inventors: Jean-Pierre Majoral, Anne-Marie Jeannine Jacqueline Caminade, Jean-Jacques Fournie, Laurent Griffe, Mary Poupot-Marsan, Remy Poupot, Cedric-Olivier Turrin